Alysa J. Mattise, Pharm.D., BCIDP, AAHIVP

About Me

Alysa Martin, PharmD, BCIDP, AAHIVP earned her doctorate of pharmacy from the University of Findlay College of Pharmacy. She completed her PGY1 Pharmacy Residency and PGY2 Infectious Diseases Pharmacy Residency training at Strong Memorial Hospital. She currently practices as a clinical pharmacy spec...

Alysa Martin, PharmD, BCIDP, AAHIVP earned her doctorate of pharmacy from the University of Findlay College of Pharmacy. She completed her PGY1 Pharmacy Residency and PGY2 Infectious Diseases Pharmacy Residency training at Strong Memorial Hospital. She currently practices as a clinical pharmacy specialist with the UR Specialty Pharmacy. Her practice areas are infectious diseases and hepatology (with a focus on viral hepatitis).

Alysa is an active member of the Society of Infectious Diseases Pharmacists (SIDP), the UR Pharmacy Wellbeing and Resiliency Committee, and the Residency Advisory Committee. She is currently the residency program director of the PGY2 Infectious Diseases residency program. Alysa serves as a preceptor for ambulatory infectious diseases rotations for PGY1 Pharmacy, PGY1 Community Pharmacy, and PGY2 Infectious Diseases Pharmacy residents. Additionally, Alysa is an adjunct faculty member for the St. John Fisher College Wegmans School of Pharmacy, and a preceptor for APPE students.

Her professional interests include expansion of clinical pharmacy services, patient education, viral hepatitis, HIV, and infectious diseases in the immunocompromised host.

Credentials

Residency & Fellowship

PGY2 Infectious Diseases Pharmacy Residency University of Rochester Medical Center 2020 - 2021

PGY1 Pharmacy Residency University of Rochester Medical Center 2019 - 2020

Education

Doctor of Pharmacy | University of Findlay. 2019

Publications

Journal Articles

Direct-Acting Antiviral Treatment Failure and Retreatment Strategies Following Hepatitis C-Positive Solid Organ Transplantation in Hepatitis C-Negative Recipients: A Multicenter Case Series.

Carver AB, Özoral C, Lange M, Mattise A, Whelchel K, Perri R

Transplant infectious disease : an official journal of the Transplantation Society.. 2025 March 24 :e70024. Epub 03/24/2025.

Incidence of Invasive Fungal Infections in Adults and Pediatric Patients With Acute Lymphoblastic Leukemia Who Received Chemotherapy

Martin A. J.; Treptow, C; Delibert, K; Melaragno, J. I.; Baran, A; O'Dwyer, K.

Journal of Hematology Oncology Pharmacy. 2024; 14(4).

Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections.

Debnath A, Pillinger KE, Martin AJ, Dobrzynski D, Cameron A, Shulder S

The Annals of pharmacotherapy.. 2023 July 57 (7):803-812. Epub 10/21/2022.

Antibiotic Use and Associated Risk Factors for Antibiotic Prescribing in COVID-19 Hospitalized Patients.

Martin AJ, Shulder S, Dobrzynski D, Quartuccio K, Pillinger KE

Journal of pharmacy practice.. 2023 April 36 (2):256-263. Epub 07/22/2021.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.